Author

P. Blattmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Pharmacology & Toxicology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

R. Aebersold· 3 shared A. Bossu· 1 shared A. Charpagne· 1 shared A. Christiansen· 1 shared A. Kirchmair· 1 shared A. Krogsdam· 1 shared A. Noureen· 1 shared A. Parisi· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

R. Aebersold

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A Novel, Uniquely Efficacious Type of CFTR Corrector with Complementary Mode of Action

V. Marchesin, L. Monnier, P. Blattmann, F. Chevillard, C. Kuntz, C. Forny, J. Kamper, R. Studer, A. Bossu, E. Ertel, O. Nayler, C. Brotschi, J. T. Williams, J. Gatfield

This paper describes a novel type-IV CFTR corrector that improves folding and trafficking of F508del-CFTR, including previously resistant mutations, through a unique binding site and mechanism.

bioRxiv · Aug 15, 2023Pharmacology & Toxicology

Functional and spatial proteomics profiling reveals intra- and intercellular signaling crosstalk in colorectal cancer

C. Plattner, G. Lamberti, P. Blattmann, A. Kirchmair, D. Rieder, Z. Loncova, G. Sturm, S. Scheidl, M. E. Ijsselsteijn, G. Fotakis, A. Noureen, R. Lisandrelli, N. Boeck, N. Nemati, A. Krogsdam, , Z. Trajanoski

The paper uses patient-derived organoids and phosphoproteomics to study signaling crosstalk in colorectal cancer and identify off-target effects of kinase inhibitors.

bioRxiv · Sep 16, 2022Cancer Biology

High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification

Y. J. Zhu, T. Weiss, Q. Zhang, R. Sun, B. Wang, Z. Wu, Q. Zhong, X. Yi, H. Gao, X. Cai, G. Ruan, T. Zhu, C. Xu, S. Lou, X. Yu, , T. Guo

This study develops a proteomic workflow for FFPE tissues to stratify prostate cancer and DLBCL samples, identifying MPO as a prognostic marker and showing FFPE's utility for biomarker discovery.

bioRxiv · Jun 11, 2019Biochemistry

PGC1a and Exercise Adaptations in Zebrafish

A. Parisi, P. Blattmann, G. Lizzo, V. Stutz, L. Strohm, J. Richard, G. Civiletto, A. Charpagne, F. Raymond, C. Gobet, B. Weger, E. Migliavacca, R. Aebersold, B. Spiegelman, P. Gut

This study shows that PGC1a induces mitochondrial biogenesis and exercise-like adaptations in zebrafish, revealing conserved exercise responses and novel ETC organization.

bioRxiv · Dec 7, 2018 · PreprintPhysiology